Work Here?
Overview
AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.
About Amboss
Industries
Data & Analytics
Enterprise Software
Education
Healthcare
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$302M
Headquarters
Berlin, Germany
Founded
2012
Get referred to Amboss
See people who can refer or advise you
Simplify's Take
What believers are saying
- AMBOSS launched AI Mode Clinical Care in the US in November 2025.
- AMBOSS posted 32 open roles in July 2026, signaling continued expansion.
- Management plans acquisitions and broader offerings for nurses and other clinicians after financing.
What critics are saying
- OpenEvidence, DynaMed, and UpToDate compress AMBOSS’s paid-clinical-workflow moat.
- FDA or EU liability scrutiny can stall AI Mode rollout after adverse clinical recommendations.
- If medical students shift to free AI tutors, AMBOSS loses its core acquisition funnel.
What makes Amboss unique
- AMBOSS unifies learning, clinical care, and teaching in one physician-built platform.
- AI Mode ranked first in Stanford-Harvard NOHARM clinical safety benchmark, February 2026.
- The March 2025 €240 million round funds international expansion and new healthcare segments.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$301.9M
Above
Industry Average
Funded Over
3 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Flexible Work Hours
Remote Work Options
Relocation Assistance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 2%STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.
BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.
Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.
In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.
Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.
Amboss is Hiring for 17 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Amboss
Industries
Data & Analytics
Enterprise Software
Education
Healthcare
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$302M
Headquarters
Berlin, Germany
Founded
2012
Amboss is Hiring for 17 Jobs on Simplify!
Find jobs on Simplify and start your career today